Jane Street’s Revelation Biosciences Warrant REVBW Stock Holding History

Jane Street’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$388	Hold	50,000	–	–	﹤0.01%	11398
2025 Q4	$400	Hold	50,000	–	–	﹤0.01%	10940
2025 Q3	$580	Hold	50,000	–	–	﹤0.01%	10648
2025 Q2	$600	Hold	50,000	–	–	﹤0.01%	9481
2025 Q1	$540	Hold	50,000	–	–	﹤0.01%	9278
2024 Q4	$350	Hold	50,000	–	–	﹤0.01%	9257
2024 Q3	$750	Hold	50,000	–	–	﹤0.01%	9467
2024 Q2	$1K	Hold	50,000	–	–	﹤0.01%	9216
2024 Q1	$1.32K	Hold	50,000	–	–	﹤0.01%	9071
2023 Q4	$530	Hold	50,000	–	–	﹤0.01%	9093
2023 Q3	$845	Hold	50,000	–	–	﹤0.01%	8509
2023 Q2	$890	Sell	50,000 -30,746	-38%	-$553	﹤0.01%	8556
2023 Q1	$1.31K	Sell	80,746 -1,814	-2%	-$46	﹤0.01%	8874
2022 Q4	$1.08K	Sell	82,560 -3,103	-4%	-$99	﹤0.01%	8962
2022 Q3	$4K	Buy	85,663 +19,889	+30%	+$1.61K	﹤0.01%	9469
2022 Q2	$5K	Sell	65,774 -9,916	-13%	-$831	﹤0.01%	9420
2022 Q1	$10K	Buy	75,690 +20,620	+37%	+$5.27K	﹤0.01%	10072
2021 Q4	$37K	Sell	55,070 -215	-0.4%	-$132	﹤0.01%	9639
2021 Q3	$34K	Sell	55,285 -4,001	-7%	-$2.42K	﹤0.01%	9649
2021 Q2	$38K	Buy	59,286 +4,609	+8%	+$2.75K	﹤0.01%	9556
2021 Q1	$28K	Buy	+54,677	New	+$51.1K	﹤0.01%	8938

Other funds holding REVBW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

SIA

Soltis Investment Advisors St. George, Utah $1.59B AUM 23.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

QWM

Quaker Wealth Management Moorestown, New Jersey $320M AUM 13.7% 1-Year Est. Return

Jane Street's REVBW Position: Q1 2026 in Review

Jane Street held its Revelation Biosciences Warrant (REVBW) position steady in Q1 2026 at 50,000 shares worth $388. The position accounts for ﹤0.01% of the portfolio, ranked #11398.

Jane Street first reported a position in REVBW in Q1 2021 and has held it in 21 quarters since. The position peaked at $38K in Q2 2021. 11 funds tracked by Wall St. Rank hold REVBW as of Q1 2026.

Jane Street held 50,000 shares of Revelation Biosciences Warrant worth $388 as of Q1 2026.
Jane Street left its Revelation Biosciences Warrant share count unchanged in Q1 2026.
Revelation Biosciences Warrant made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11398 holding.
Jane Street first reported a position in Revelation Biosciences Warrant in Q1 2021 and has held it in 21 quarters since.
Jane Street's Revelation Biosciences Warrant position peaked at $38K in Q2 2021.
11 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.